BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND KMT2C, ENSG00000055609, MLL3, 58508
26 results:

  • 1. Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
    Zheng L; Zhou N; Yang X; Wei Y; Yi C; Gou H
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102244. PubMed ID: 37944749
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessing the Genomic Landscape of Cervical cancers: Clinical Opportunities and Therapeutic Targets.
    Friedman CF; Ravichandran V; Miller K; Vanderbilt C; Zhou Q; Iasonos A; Vivek M; Mishra P; Leitao MM; Broach V; Sonoda Y; Kyi C; Zamarin D; O'Cearbhaill RE; Konner J; Berger MF; Weigelt B; Momeni Boroujeni A; Park KJ; Aghajanian C; Solit DB; Donoghue MTA
    Clin Cancer Res; 2023 Nov; 29(22):4660-4668. PubMed ID: 37643132
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Relationship Between Gene Mutations and the Clinicopathological Features and Prognosis of gastric cancer.
    Nie Z; Zeng K; Yan Q; Liu Y; Bian Y; Zhu J; Guo Z; He F; Shi H; Guo Y
    Int J Surg Pathol; 2024 May; 32(3):486-495. PubMed ID: 37545327
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular profiling of gastric neuroendocrine carcinomas.
    Ikegame K; Hatakeyama K; Terashima M; Sugino T; Aizawa D; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
    Eur J Surg Oncol; 2023 Sep; 49(9):106987. PubMed ID: 37463826
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma.
    Sun B; Chen H; Lao J; Tan C; Zhang Y; Shao Z; Xu D
    J Pathol Clin Res; 2023 Sep; 9(5):409-422. PubMed ID: 37395342
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer.
    Kung CY; Fang WL; Hung YP; Huang KH; Chen MH; Chao Y; Lin SC; Li AF; Lo SS; Wu CW
    Aging (Albany NY); 2023 Feb; 15(3):777-790. PubMed ID: 36779847
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients.
    Yao J; You Q; Zhang X; Zhang Y; Xu J; Zhao X; Li J; Wang X; Gong Z; Zhang D; Wang W
    Clin Genet; 2023 Feb; 103(2):200-208. PubMed ID: 36346122
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive Analysis of Large-Scale Transcriptomes from Multiple cancer Types.
    Nong B; Guo M; Wang W; Songyang Z; Xiong Y
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946814
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. KMT2D promotes proliferation of gastric cancer cells: evidence from ctDNA sequencing.
    Li Q; Wu R; Wu F; Chen Q
    J Clin Lab Anal; 2021 Apr; 35(4):e23721. PubMed ID: 33793001
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
    Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
    Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
    Hao D; He S; Harada K; Pizzi MP; Lu Y; Guan P; Chen L; Wang R; Zhang S; Sewastjanow-Silva M; Abdelhakeem A; Shanbhag N; Bhutani M; Han G; Lee JH; Zhao S; Weston B; Blum Murphy M; Waters R; Estrella JS; Roy-Chowdhuri S; Gan Q; Lee JS; Peng G; Hanash SM; Calin GA; Song X; Zhang J; Song S; Wang L; Ajani JA
    Gut; 2021 Nov; 70(11):2055-2065. PubMed ID: 33334899
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/mll3/GRHL2 signaling cascade.
    Zhang Y; Meng W; Yue P; Li X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):134. PubMed ID: 32660626
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
    Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
    Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Cho SJ; Yoon C; Lee JH; Chang KK; Lin JX; Kim YH; Kook MC; Aksoy BA; Park DJ; Ashktorab H; Smoot DT; Schultz N; Yoon SS
    Clin Cancer Res; 2018 Dec; 24(24):6556-6569. PubMed ID: 30108106
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clonal Structures of Regionally Synchronous gastric Adenomas and Carcinomas.
    Jung SH; Kim SY; An CH; Lee SH; Jung ES; Park HC; Kim MS; Chung YJ; Lee SH
    Clin Cancer Res; 2018 Oct; 24(19):4715-4725. PubMed ID: 29945994
    [No Abstract]    [Full Text] [Related]  

  • 16. Clinical Relevance and Molecular Phenotypes in gastric cancer, of TP53 Mutations and Gene Expressions, in Combination With Other Gene Mutations.
    Park S; Lee J; Kim YH; Park J; Shin JW; Nam S
    Sci Rep; 2016 Oct; 6():34822. PubMed ID: 27708434
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comprehensive mutation profiling of mucinous gastric carcinoma.
    Rokutan H; Hosoda F; Hama N; Nakamura H; Totoki Y; Furukawa E; Arakawa E; Ohashi S; Urushidate T; Satoh H; Shimizu H; Igarashi K; Yachida S; Katai H; Taniguchi H; Fukayama M; Shibata T
    J Pathol; 2016 Oct; 240(2):137-48. PubMed ID: 27313181
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
    Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.
    Katoh M
    Epigenomics; 2016 Feb; 8(2):285-305. PubMed ID: 26411517
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Association of mll3 expression with prognosis in gastric cancer.
    Li B; Liu HY; Guo SH; Sun P; Gong FM; Jia BQ
    Genet Mol Res; 2014 Sep; 13(3):7513-8. PubMed ID: 25222251
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.